_________ false
אורמד פארמסוטיקלס אינק 2 381
ORAMED PHARMACEUTICALS INC
Corporation no: 980376008 11706

Israel Securities Authority   Tel Aviv Stock Exchange   C003 ( Public )   Reported via MAGNA: 08/07/2018
  www.isa.gov.il     www.tase.co.il       Reference: 2018-02-061131 Time of broadcast: 00:04 00:03:23

Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000


Delay the publication of a report _________ _________
1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.
2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.


The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on
Press_Release_Closing_July_2018_FINAL_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
       

Stock Exchange/Market: -1 Date of revision of form structure: 01/07/2018
Address: Hi-tech Park, Givat Ram 2/4 p.o.b 39098 , Jerusalem 91390   , Israel Tel: 02-5660001 , 02-5788763 Fax: 02-5660004
E-mail address: yifat@ormed.com   Company site: www.ermed.com

Previous names of reporting entity:

Name of the Signatory: EISENBERG AVIZOHAR Hilla Position of Signatory in the reporting corporation: CFO & Secretary Name of Employer Company:
Address: Hi-Tech Park, Givat Ram 2/4 , Jerusalem 91390 Telephone: 02-5660001 Facsimile: 02-5660004 E-mail: hilla@oramed.com 2
Israel